mRNA Synthesis Reagents Product Catalogue
We present a whitepaper on one-stop high-performance reagents and customized services covering the full workflow of mRNA in vitro transcription, modification and production.
Key Insights:
- Industry Challenges: The mRNA manufacturing process faces multiple pain points, including unstable transcription yield, incomplete capping and poly(A) tailing, residual DNA/impurities, RNA degradation, and a lack of integrated high-quality raw materials and supporting enzymes for full-process production.
- Proposed Solution: Provide a comprehensive portfolio of mRNA synthesis reagents including restriction enzymes, RNA polymerases, functional enzymes, NTPs, diverse cap analogs and supporting kits, alongside cGMP-compliant custom mRNA synthesis and CDMO services to cover the entire mRNA production chain.
-
Key Benefits:
- Full-process product layout covering template linearization, IVT, capping, poly(A) tailing and impurity removal
- High enzymatic activity, high capping efficiency and low impurities, ensuring high integrity and quality of finished mRNA
- Diversified products compatible with conventional and modified mRNA, supporting RUO and clinical-grade production demands
- Choosing mRNA Synthesis Reagents & Suppliers: Key criteria include complete product lineup, reagent purity and stability, compatibility with mainstream IVT systems, strict quality control standards, and mature customized production and CDMO capabilities.
- Hongene's Role: As a professional supplier of nucleic acid raw materials and mRNA synthesis reagents, Hongene offers standardized enzymes, NTPs, cap analogs and ready-to-use kits, and delivers customized mRNA production services. It supports customers from early-stage research to clinical development for mRNA vaccines, drugs and related research projects.
(To explore detailed product specifications, reaction protocols, ordering information and customized service solutions, download the complete whitepaper.)